Coagulation Profile B.V. partners with 2M Engineering Ltd (Valkenswaard) and FOCE B.V. (Maria Hoop) in a new OPzuid financed project: Personalisation of Thrombosis Treatement (PoTT).
The PoTT (Personalisation of Thrombosis Treatment) project aims to develop a reliable, fast, and easy-to-use device, HemCare, that enables healthcare providers to accurately measure a patient’s blood clotting and the balance between coagulation and anticoagulation. By offering personalised anticoagulation dosing based on precise measurements, HemCare will significantly reduce the risks associated with incorrect thrombosis medication.
The project involves a consortium of partners, including 2M Engineering, Coagulation Profile B.V., FOCE Technology, and Maastricht University, and focuses on creating a commercial product that improves patient care in primary healthcare settings, supporting personalisation of thrombosis treatment approaches.
Read more at: PoTT Project
Comments